Clinical trial
Combination Chemotherapy for the Treatment of Indian Kala-Azar
NCT00370825 · Banaras Hindu University, Other · Completed
Key facts
| NCT number | NCT00370825 |
|---|---|
| Title | Combination Chemotherapy for the Treatment of Indian Kala-Azar |
| Official title | Combination Chemotherapy for the Treatment of Indian Visceral Leishmaniasis: Miltefosine Plus Liposomal Amphotericin B - Dose and Duration Ranging Study |
| Lead sponsor | Banaras Hindu University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Visceral Leishmaniasis |
| Intervention type | Drug |
| Interventions | Combination therapy with AmBisome and miltefosine |
| Enrollment | 200 |
| Start date | Sep 1, 2006 |
| First posted | Sep 1, 2006 |
| Last update posted | Sep 12, 2008 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: